Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Intangibles: 2019-2024

Historic Intangibles for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to $34.9 million.

  • Eton Pharmaceuticals' Intangibles rose 444.55% to $31.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.9 million, marking a year-over-year increase of 444.55%. This contributed to the annual value of $34.9 million for FY2024, which is 636.04% up from last year.
  • As of FY2024, Eton Pharmaceuticals' Intangibles stood at $34.9 million, which was up 636.04% from $4.7 million recorded in FY2023.
  • Over the past 5 years, Eton Pharmaceuticals' Intangibles peaked at $34.9 million during FY2024, and registered a low of $575,000 during FY2020.
  • In the last 3 years, Eton Pharmaceuticals' Intangibles had a median value of $4.8 million in 2022 and averaged $14.8 million.
  • Per our database at Business Quant, Eton Pharmaceuticals' Intangibles decreased by 20.69% in 2020 and then surged by 636.04% in 2024.
  • Eton Pharmaceuticals' Intangibles (Yearly) stood at $575,000 in 2020, then skyrocketed by 529.74% to $3.6 million in 2021, then soared by 31.29% to $4.8 million in 2022, then fell by 0.32% to $4.7 million in 2023, then skyrocketed by 636.04% to $34.9 million in 2024.